Successful introduction and audit of a step-down oral antibiotic strategy for low risk paediatric febrile neutropaenia in a UK, multicentre, shared care setting

European Journal of Cancer

Volumn 45, Issue 16, 2009, Pages 2843-2849

  Dommett, R ^a   Geary, J ^b   Freeman, S ^b   Hartley, J ^c   Sharland, M ^d   Davidson, A ^e   Tulloh, R ^f   Taj, M ^g   Stoneham, S ^h   Chisholm, J C ^c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b Bexley Care Trust   (United Kingdom)

^c GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^d ST GEORGE S HOSPITAL   (United Kingdom)

^e ROYAL ALEXANDRA CHILDREN S HOSPITAL   (United Kingdom)

^f QUEEN MARY S HOSPITAL   (United Kingdom)

^g ROYAL MARSDEN HOSPITAL   (United Kingdom)

^h UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Cancer; Children; Fever; Infection; Neutropaenia; Risk; Therapy

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; CIPROFLOXACIN; CLARITHROMYCIN; GENTAMICIN; PIPERACILLIN PLUS TAZOBACTAM;

ANTIBIOTIC THERAPY; ARTICLE; BLOOD CULTURE; CLINICAL TRIAL; FEBRILE NEUTROPENIA; HOSPITAL READMISSION; HUMAN; INFANT; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; UNITED KINGDOM;

ADMINISTRATION, ORAL; ADOLESCENT; ANTI-INFECTIVE AGENTS; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; FEASIBILITY STUDIES; FEVER; HUMANS; INFANT; INFECTION; NEOPLASMS; NEUTROPENIA; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; RISK FACTORS; TREATMENT OUTCOME;

EID: 70350102550     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2009.06.003     Document Type: Article

References (30)

1. Hann I., Viscoli C., Paesmans M., Gaya M., and Galuser M. A comparison of outcome from febrile neutropenic episodes in children compared with adults: results from four EORTC studies. International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organization for Research and Treatment of Cancer (EORTC). Brit J Haematol 99 (1997) 580-588
2. Basu S.K., Fernandez I.D., Fisher S.G., Asselin B.L., and Lyman G.H. Length of stay and mortality associated with febrile neutropenia among children with cancer. J Clin Oncol 23 (2005) 7958-7966
3. Orudjev E., and Lange B.J. Evolving concepts of management of febrile neutropenia in children with cancer. Med Pediatr Oncol 39 (2002) 77-85
4. Chisholm J.C., and Dommett R. The evolution towards ambulatory and day-case therapy for febrile neutropenia. Brit J Haematol 135 (2006) 3-16
5. Phillips B., Selwood K., Lane S.M., et al. Variation in policies for the management of febrile neutropenia in United Kingdom Children's Cancer Study Group centres. Arch Dis Child 92 (2007) 495-498
6. Phillips R., Skinner R., and Chisholm J.C. Treating LR Febrile neutropenia - Jenny's story. Arch Dis Child 92 (2007) 7-8
7. Talcott J.A., Finberg R., Mayer R.J., and Goldman L. The medical course of cancer patients with fever and neutropenia. Clinical identification of a low-risk subgroup at presentation. Arch Intern Med 148 (1988) 2561-2568
8. Talcott J.A., Siegel R.D., Finberg R., and Goldman L. Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction rule. J Clin Oncol 10 (1992) 316-322
9. Klastersky J., Paesmans M., Rubenstein E.B., et al. The Multinational Association for Supportive Care in Cancer risk index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol 18 (2000) 3038-3051
10. Klaassen R.J., Goodman T.R., Pham B., and Doyle J.J. "Low-risk" prediction rule for pediatric oncology patients presenting with fever and neutropenia. J Clin Oncol 18 (2000) 1012-1019
11. Rackoff W.R., Gonin R., Robinson C., Kreissman S.G., and Breitfeld P.B. Predicting the risk of bacteremia in children with fever and neutropenia. J Clin Oncol 14 (1996) 919-924
12. Santolaya M.E., Alvarez A.M., Becker A., et al. Prospective, multicenter evaluation of risk factors associated with invasive bacterial infection in children with cancer, neutropenia, and fever. J Clin Oncol 19 (2001) 3415-3421
13. Santolaya M.E., Alvarez A.M., Aviles C.L., et al. Prospective evaluation of a model of prediction of invasive bacterial infection risk among children with cancer, fever, and neutropenia. Clin Infect Dis 35 (2002) 678-683
14. Lucas K.G., Brown A.E., Armstrong D., Chapman D., and Heller G. The identification of febrile, neutropenic children with neoplastic disease at LR for bacteremia and complications of sepsis. Cancer 77 (1996) 791-798
15. Alexander S.W., Wade K.C., Hibberd P.L., and Parsons S.K. Evaluation of risk prediction criteria for episodes of febrile neutropenia in children with cancer. J Pediatr Hematol/Oncol 24 (2002) 28-42
16. Ammann R.A., Hirt A., Lüthy A.R., and Aebi C. Identification of children presenting with fever in chemotherapy-induced neutropenia at LR for severe bacterial infection. Med Pediatr Oncol 41 (2003) 436-443
17. Baorto E.P., Aquino V.M., Mullen C.A., Buchanan G.R., and DeBaun M.R. Clinical parameters associated with low bacteremia risk in 1100 pediatric oncology patients with fever and neutropenia. Cancer 92 (2001) 909-913
18. de Bont E.S., Vellenga E., Swaanenburg J.C., et al. Plasma IL-8 and IL-6 levels can be used to define a group with low risk of septicaemia among cancer patients with fever and neutropenia. Brit J Haematol 107 (1999) 375-380
19. Te Poele EM, Tissing WJ, Kamps WA, de Bont ES. Risk assessment in fever and neutropenia in children with cancer: what did we learn? Crit Rev Oncol Hematol 2009;February 3 [Epub ahead of print].
20. Duncan C., Chisholm J.C., Freeman S., et al. A prospective study of admissions for febrile neutropenia in secondary paediatrics units in South East England. Pediatr Blood Cancer 49 (2007) 678-681
21. Quezada G., Sunderland T., Chan K.W., Rolston K., and Mullen C.A. Medical and non-medical barriers to outpatient treatment of fever and neutropenia in children with cancer. Pediatr Blood Cancer 48 (2007) 273-277
22. Lau R.C., Doyle J.J., Freedman M.H., King S.M., and Richardson S.E. Early discharge of pediatric febrile neutropenic cancer patients by substitution of oral for intravenous antibiotics. Pediatr Hematol Oncol 11 (1994) 417-421
23. Paganini H.R., Sarkis C.M., De Martino M.G., et al. Oral administration of cefixime to lower risk febrile neutropenic children with cancer. Cancer 88 (2000) 2848-2852
24. Paganini H., Gomez S., Ruvinsky S., et al. Outpatient, sequential, parenteral-oral antibiotic therapy for lower risk febrile neutropenia in children with malignant disease: a single-center, randomized, controlled trial in Argentina. Cancer 97 (2003) 1775-1780
25. Rondinelli P.I., Ribeiro K.deC., and de Camargo B. A proposed score for predicting severe infection complications in children with chemotherapy-induced febrile neutropenia. J Pediatr Hematol Oncol 28 (2006) 665-670
26. Freifeld A., Marchigiani D., Walsh T., et al. A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy. New Engl J Med 341 (1999) 305-311
27. Kern W.V., Cometta A., De Bock R., et al. Oral versus intravenous empirical antimicrobial therapy for fever in patients with granulocytopenia who are receiving cancer chemotherapy. International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer. New Engl J Med 341 (1999) 312-318
28. Laddie J., and Chisholm J.C. A survey of parent and staff views on management by risk stratification in children with febrile neutropenia. Pediatr Blood Cancer 49 (2007) 508-509 [abstract]
29. Mullen C.A., Petropoulos D., Roberts W.M., et al. Economic and resource utilization analysis of outpatient management of fever and neutropenia in low-risk pediatric patients with cancer. J Pediatr Hematol Oncol 21 (1999) 212-218
30. Ahmed N., El-Mahallawy H.A., Ahmed I.A., et al. Early hospital discharge versus continued hospitalisation in febrile paediatric cancer patients with prolonged neutropenia: a randomized, prospective study. Pediatr Blood Cancer 49 (2007) 786-792